A Pilot Study Evaluating Oral Triamcinalone in Patients With Androgen Independent Prostate Cancer

NCT00186108 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

23

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Oral Triamcinalone

Sponsor

Stanford University

Collaborators

[object Object]